SHJBF

Shanghai Junshi Biosciences Co., Ltd.

USD

Set alert

Price alert · SHJBF

All alert types
3.35 USD 0.00 0.00%
As of Oct 29, 2026
3.08 Day range 3.08
2.99 52-week range 4.23
YTD
+8.77%
1 year
-20.80%
Open
3.08
Prev close
3.35
Mkt cap
3.44B
Vol
100
Avg vol
0
EPS
-0.12
P/E
0.00
More statistics
Low
3.08
High
3.08

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for SHJBF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

1.44 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -25.6×
FY 2016: -468×FY 2017: -177×FY 2018: -66.2×FY 2019: -83.9×FY 2020: -37.0×FY 2021: -89.8×FY 2022: -14.9×FY 2023: -6.6×FY 2024: -11.1×FY 2025: -25.6×
FY 2016 5y median -14.9× FY 2025
P/S 8.9×
FY 2016: 16088×FY 2017: 49338×FY 2018: 50733×FY 2019: 80.6×FY 2020: 38.6×FY 2021: 16.1×FY 2022: 24.4×FY 2023: 10.0×FY 2024: 7.3×FY 2025: 8.9×
FY 2016 5y median 10.0× FY 2025
P/B 3.6×
FY 2016: 53.6×FY 2017: 50.5×FY 2018: 14.3×FY 2019: 20.9×FY 2020: 10.5×FY 2021: 8.1×FY 2022: 3.7×FY 2023: 2.1×FY 2024: 2.4×FY 2025: 3.6×
FY 2016 5y median 3.6× FY 2025
P/FCF -17.8×
FY 2016: -157×FY 2017: -83.2×FY 2018: -44.4×FY 2019: -30.5×FY 2020: -29.5×FY 2021: -42.4×FY 2022: -16.3×FY 2023: -5.3×FY 2024: -6.6×FY 2025: -17.8×
FY 2016 5y median -16.3× FY 2025
EV/EBITDA -38.7×
FY 2016: -492×FY 2017: -186×FY 2018: -65.9×FY 2019: -90.0×FY 2020: -39.7×FY 2021: -201×FY 2022: -13.1×FY 2023: -6.0×FY 2024: -14.3×FY 2025: -38.7×
FY 2016 5y median -14.3× FY 2025
EV/Sales 9.5×
FY 2016: 16058×FY 2017: 49106×FY 2018: 48385×FY 2019: 80.1×FY 2020: 37.0×FY 2021: 15.4×FY 2022: 21.2×FY 2023: 8.7×FY 2024: 7.5×FY 2025: 9.5×
FY 2016 5y median 9.5× FY 2025
FCF Yield -5.6%
FY 2016: -0.6%FY 2017: -1.2%FY 2018: -2.3%FY 2019: -3.3%FY 2020: -3.4%FY 2021: -2.4%FY 2022: -6.1%FY 2023: -19.0%FY 2024: -15.1%FY 2025: -5.6%
FY 2016 5y median -6.1% FY 2025

Profitability

Gross Margin 72.3%
FY 2016: 73.8%FY 2017: 61.1%FY 2018: 71.4%FY 2019: 88.3%FY 2020: 76.6%FY 2021: 68.7%FY 2022: 63.8%FY 2023: 55.6%FY 2024: 74.4%FY 2025: 72.3%
FY 2016 5y median 68.7% FY 2025
Operating Margin -37.4%
FY 2016: -653.0%FY 2017: -3871.1%FY 2018: -11205.6%FY 2019: -15.1%FY 2020: -104.6%FY 2021: -14.7%FY 2022: -189.3%FY 2023: -163.2%FY 2024: -66.7%FY 2025: -37.4%
FY 2016 5y median -66.7% FY 2025
Net Margin -35.0%
FY 2016: -3512.6%FY 2017: -27948.1%FY 2018: -76703.9%FY 2019: -96.0%FY 2020: -104.4%FY 2021: -17.9%FY 2022: -164.2%FY 2023: -151.9%FY 2024: -65.8%FY 2025: -35.0%
FY 2016 5y median -65.8% FY 2025
ROE -14.1%
FY 2016: -11.7%FY 2017: -28.6%FY 2018: -21.6%FY 2019: -24.9%FY 2020: -28.5%FY 2021: -9.0%FY 2022: -25.2%FY 2023: -31.8%FY 2024: -21.8%FY 2025: -14.1%
FY 2016 5y median -21.8% FY 2025
ROIC -8.2%
FY 2016: -2.2%FY 2017: -3.8%FY 2018: -2.6%FY 2019: -2.9%FY 2020: -24.5%FY 2021: -6.5%FY 2022: -23.7%FY 2023: -25.9%FY 2024: -14.1%FY 2025: -8.2%
FY 2016 5y median -14.1% FY 2025
ROA -6.9%
FY 2016: -11.5%FY 2017: -26.3%FY 2018: -16.8%FY 2019: -16.8%FY 2020: -20.8%FY 2021: -6.5%FY 2022: -19.0%FY 2023: -20.1%FY 2024: -11.9%FY 2025: -6.9%
FY 2016 5y median -11.9% FY 2025

Growth (YoY)

Revenue 24.9%
FY 2016: 30.1%FY 2017: -69.4%FY 2018: -18.6%FY 2019: 82886.0%FY 2020: 105.8%FY 2021: 152.4%FY 2022: -63.9%FY 2023: 3.4%FY 2024: 29.7%FY 2025: 24.9%
FY 2016 FY 2025
Operating Income 30.1%
FY 2016: 69.7%FY 2017: -81.1%FY 2018: -135.5%FY 2019: -12.0%FY 2020: -1322.9%FY 2021: 64.5%FY 2022: -364.2%FY 2023: 10.9%FY 2024: 47.0%FY 2025: 30.1%
FY 2016 FY 2025
EPS (diluted) 35.4%
FY 2016: 34.6%FY 2017: -147.1%FY 2018: -183.3%FY 2019: 20.2%FY 2020: -112.6%FY 2021: 59.9%FY 2022: -221.0%FY 2023: 10.8%FY 2024: 44.0%FY 2025: 35.4%
FY 2016 FY 2025
Free Cash Flow 43.1%
FY 2016: -148.3%FY 2017: -76.9%FY 2018: -56.8%FY 2019: -91.9%FY 2020: -2.0%FY 2021: 26.9%FY 2022: -42.0%FY 2023: -31.3%FY 2024: 25.1%FY 2025: 43.1%
FY 2016 FY 2025

Financial Health

Current Ratio 1.6×
FY 2016: 28.7×FY 2017: 8.7×FY 2018: 6.2×FY 2019: 3.2×FY 2020: 3.1×FY 2021: 2.9×FY 2022: 4.1×FY 2023: 2.2×FY 2024: 1.7×FY 2025: 1.6×
FY 2016 5y median 2.2× FY 2025
Quick Ratio 1.4×
FY 2016: 28.4×FY 2017: 8.2×FY 2018: 6.1×FY 2019: 2.9×FY 2020: 2.9×FY 2021: 2.7×FY 2022: 3.7×FY 2023: 2.0×FY 2024: 1.5×FY 2025: 1.4×
FY 2016 5y median 2.0× FY 2025
Debt / Equity 0.7×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.2×FY 2019: 0.3×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.2×FY 2024: 0.5×FY 2025: 0.7×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA -2.5×
FY 2016: 0.9×FY 2017: 0.9×FY 2018: 3.2×FY 2019: 0.5×FY 2020: 1.7×FY 2021: 9.3×FY 2022: 2.0×FY 2023: 0.9×FY 2024: -0.4×FY 2025: -2.5×
FY 2016 5y median 0.9× FY 2025
Interest Coverage -12.4×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: -50.3×FY 2019: -8.8×FY 2020: -56.8×FY 2021: -27.1×FY 2022: -93.7×FY 2023: -84.5×FY 2024: -25.3×FY 2025: -12.4×
FY 2016 5y median -27.1× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.1%FY 2020: 0.1%FY 2021: 0.0%FY 2022: 0.1%FY 2023: 0.3%FY 2024: 0.5%FY 2025: 0.0%
FY 2016 5y median 0.1% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -7.9%FY 2020: -2.6%FY 2021: -2.3%FY 2022: -0.8%FY 2023: -1.7%FY 2024: -5.8%FY 2025: 0.0%
FY 2016 5y median -1.7% FY 2025

Annual · latest fiscal year ends 2025-12-31